{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:18:29Z","timestamp":1792588709111,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:00:00Z","timestamp":1317772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Adiponectin, a fat tissue-derived adipokine, exhibits beneficial effects against insulin resistance, cardiovascular disease, inflammatory conditions, and cancer. Circulating adiponectin levels are decreased in obese individuals, and this feature correlates with increased risk of developing several metabolic, immunological and neoplastic diseases. Thus, pharmacological replacement of adiponectin might prove clinically beneficial, especially for the obese patient population. At present, adiponectin-based therapeutics are not available, partly due to yet unclear structure\/function relationships of the cytokine and difficulties in converting the full size adiponectin protein into a viable drug.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We aimed to generate adiponectin-based short peptide that can mimic adiponectin action and be suitable for preclinical and clinical development as a cancer therapeutic. Using a panel of 66 overlapping 10 amino acid-long peptides covering the entire adiponectin globular domain (residues 105-254), we identified the 149-166 region as the adiponectin active site. Three-dimensional modeling of the active site and functional screening of additional 330 peptide analogs covering this region resulted in the development of a lead peptidomimetic, ADP 355 (H-<jats:underline>D<\/jats:underline>Asn-Ile-Pro-Nva-Leu-Tyr-<jats:underline>D<\/jats:underline>Ser-Phe-Ala-<jats:underline>D<\/jats:underline>Ser-NH<jats:sub>2<\/jats:sub>). In several adiponectin receptor-positive cancer cell lines, ADP 355 restricted proliferation in a dose-dependent manner at 100 nM-10 \u03bcM concentrations (exceeding the effects of 50 ng\/mL globular adiponectin). Furthermore, ADP 355 modulated several key signaling pathways (AMPK, Akt, STAT3, ERK1\/2) in an adiponectin-like manner. siRNA knockdown experiments suggested that ADP 355 effects can be transmitted through both adiponectin receptors, with a greater contribution of AdipoR1.<jats:italic>In vivo<\/jats:italic>, intraperitoneal administration of 1 mg\/kg\/day ADP 355 for 28 days suppressed the growth of orthotopic human breast cancer xenografts by ~31%. The peptide displayed excellent stability (at least 30 min) in mouse blood or serum and did not induce gross toxic effects at 5-50 mg\/kg bolus doses in normal CBA\/J mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ADP 355 is a first-in-class adiponectin receptor agonist. Its biological activity, superior stability in biological fluids as well as acceptable toxicity profile indicate that the peptidomimetic represents a true lead compound for pharmaceutical development to replace low adiponectin levels in cancer and other malignancies.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1472-6750-11-90","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T18:47:50Z","timestamp":1317840470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Design and development of a peptide-based adiponectin receptor agonist for cancer treatment"],"prefix":"10.1186","volume":"11","author":[{"suffix":"Jr","given":"Laszlo","family":"Otvos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Haspinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"La Russa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Maspero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Kovalszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandor","family":"Lovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Nama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Knappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Surmacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"issue":"2","key":"649_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.bjc.6604166","volume":"98","author":"ME Grossmann","year":"2008","unstructured":"Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP: Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer. 2008, 98 (2): 370-379. 10.1038\/sj.bjc.6604166.","journal-title":"Br J Cancer"},{"issue":"8","key":"649_CR2","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2337\/diacare.26.8.2383","volume":"26","author":"AS Ryan","year":"2003","unstructured":"Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D: Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care. 2003, 26 (8): 2383-2388. 10.2337\/diacare.26.8.2383.","journal-title":"Diabetes Care"},{"issue":"2","key":"649_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1517\/14728220903530712","volume":"14","author":"P Chiarugi","year":"2010","unstructured":"Chiarugi P, Fiaschi T: Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration. Expert Opin Ther Targets. 2010, 14 (2): 193-206. 10.1517\/14728220903530712.","journal-title":"Expert Opin Ther Targets"},{"key":"649_CR4","volume-title":"Med Oncol","author":"X Chen","year":"2010","unstructured":"Chen X, Wang Y: Adiponectin and breast cancer. Med Oncol. 2010"},{"issue":"4","key":"649_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1253\/circj.CJ-09-0057","volume":"73","author":"R Shibata","year":"2009","unstructured":"Shibata R, Ouchi N, Murohara T: Adiponectin and cardiovascular disease. Circ J. 2009, 73 (4): 608-614. 10.1253\/circj.CJ-09-0057.","journal-title":"Circ J"},{"issue":"2","key":"649_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","volume":"316","author":"S Galic","year":"2010","unstructured":"Galic S, Oakhill JS, Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010, 316 (2): 129-139. 10.1016\/j.mce.2009.08.018.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"649_CR7","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","volume":"86","author":"D Barb","year":"2007","unstructured":"Barb D, Williams CJ, Neuwirth AK, Mantzoros CS: Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr. 2007, 86 (3): s858-866.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"649_CR8","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11033-010-0179-y","volume":"38","author":"PF Hu","year":"2010","unstructured":"Hu PF, Bao JP, Wu LD: The emerging role of adipokines in osteoarthritis: a narrative review. Mol Biol Rep. 2010, 38 (2): 873-878.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"649_CR9","doi-asserted-by":"publisher","first-page":"258S","DOI":"10.3945\/ajcn.2009.28449C","volume":"91","author":"F Ziemke","year":"2010","unstructured":"Ziemke F, Mantzoros CS: Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010, 91 (1): 258S-261S. 10.3945\/ajcn.2009.28449C.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"649_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ncpendmet0456","volume":"3","author":"A Schaffler","year":"2007","unstructured":"Schaffler A, Scholmerich J, Buechler C: Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab. 2007, 3 (4): 345-354. 10.1038\/ncpendmet0456.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"649_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12020-009-9278-8","volume":"37","author":"K Brochu-Gaudreau","year":"2010","unstructured":"Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF: Adiponectin action from head to toe. Endocrine. 2010, 37 (1): 11-32. 10.1007\/s12020-009-9278-8.","journal-title":"Endocrine"},{"issue":"Pt 5","key":"649_CR12","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1042\/BST0340798","volume":"34","author":"X Fang","year":"2006","unstructured":"Fang X, Sweeney G: Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem Soc Trans. 2006, 34 (Pt 5): 798-801.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"649_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2337\/diabetes.52.6.1355","volume":"52","author":"X Wu","year":"2003","unstructured":"Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ: Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes. 2003, 52 (6): 1355-1363. 10.2337\/diabetes.52.6.1355.","journal-title":"Diabetes"},{"issue":"50","key":"649_CR14","doi-asserted-by":"publisher","first-page":"50810","DOI":"10.1074\/jbc.M309469200","volume":"278","author":"TS Tsao","year":"2003","unstructured":"Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, Heuser JE, Lodish HF: Role of disulfide bonds in Acrp30\/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem. 2003, 278 (50): 50810-50817. 10.1074\/jbc.M309469200.","journal-title":"J Biol Chem"},{"issue":"25","key":"649_CR15","doi-asserted-by":"publisher","first-page":"16309","DOI":"10.1073\/pnas.222657499","volume":"99","author":"E Tomas","year":"2002","unstructured":"Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI, Lodish HF, Ruderman NB: Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA. 2002, 99 (25): 16309-16313. 10.1073\/pnas.222657499.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6941","key":"649_CR16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003, 423 (6941): 762-769. 10.1038\/nature01705.","journal-title":"Nature"},{"issue":"3","key":"649_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev. 2005, 26 (3): 439-451. 10.1210\/er.2005-0005.","journal-title":"Endocr Rev"},{"issue":"8","key":"649_CR18","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2337\/diabetes.53.8.2132","volume":"53","author":"H Wang","year":"2004","unstructured":"Wang H, Zhang H, Jia Y, Zhang Z, Craig R, Wang X, Elbein SC: Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance. Diabetes. 2004, 53 (8): 2132-2136. 10.2337\/diabetes.53.8.2132.","journal-title":"Diabetes"},{"issue":"3","key":"649_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nm1557","volume":"13","author":"T Yamauchi","year":"2007","unstructured":"Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, et al: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007, 13 (3): 332-339. 10.1038\/nm1557.","journal-title":"Nat Med"},{"issue":"2","key":"649_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cmet.2011.01.012","volume":"13","author":"T Kadowaki","year":"2011","unstructured":"Kadowaki T, Yamauchi T: Adiponectin receptor signaling: a new layer to the current model. Cell Metab. 2011, 13 (2): 123-124. 10.1016\/j.cmet.2011.01.012.","journal-title":"Cell Metab"},{"issue":"44","key":"649_CR21","doi-asserted-by":"publisher","first-page":"33623","DOI":"10.1074\/jbc.M109.085084","volume":"285","author":"N Wijesekara","year":"2010","unstructured":"Wijesekara N, Krishnamurthy M, Bhattacharjee A, Suhail A, Sweeney G, Wheeler MB: Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem. 2010, 285 (44): 33623-33631. 10.1074\/jbc.M109.085084.","journal-title":"J Biol Chem"},{"issue":"5","key":"649_CR22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/jcb.22634","volume":"110","author":"JA Handy","year":"2010","unstructured":"Handy JA, Saxena NK, Fu P, Lin S, Mells JE, Gupta NA, Anania FA: Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3). J Cell Biochem. 2010, 110 (5): 1195-1207. 10.1002\/jcb.22634.","journal-title":"J Cell Biochem"},{"issue":"3","key":"649_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jcb.22745","volume":"111","author":"S Akifusa","year":"2010","unstructured":"Akifusa S, Kamio N, Shimazaki Y, Yamaguchi N, Nonaka K, Yamashita Y: Involvement of the JAK-STAT pathway and SOCS3 in the regulation of adiponectin-generated reactive oxygen species in murine macrophage RAW 264 cells. J Cell Biochem. 2010, 111 (3): 597-606. 10.1002\/jcb.22745.","journal-title":"J Cell Biochem"},{"issue":"11","key":"649_CR24","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1093\/carcin\/bgn194","volume":"29","author":"J Liu","year":"2008","unstructured":"Liu J, Lam JB, Chow KH, Xu A, Lam KS, Moon RT, Wang Y: Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1. Carcinogenesis. 2008, 29 (11): 2195-2202. 10.1093\/carcin\/bgn194.","journal-title":"Carcinogenesis"},{"issue":"1","key":"649_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2005.05.076","volume":"333","author":"T Miyazaki","year":"2005","unstructured":"Miyazaki T, Bub JD, Uzuki M, Iwamoto Y: Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun. 2005, 333 (1): 79-87. 10.1016\/j.bbrc.2005.05.076.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"649_CR26","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1210\/jc.2006-1858","volume":"92","author":"A Korner","year":"2007","unstructured":"Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, et al: Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007, 92 (3): 1041-1048.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"649_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2337\/diacare.29.01.06.dc05-1364","volume":"29","author":"Y Hattori","year":"2006","unstructured":"Hattori Y, Hattori S, Kasai K: Globular adiponectin activates nuclear factor-kappaB in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diabetes Care. 2006, 29 (1): 139-141. 10.2337\/diacare.29.01.06.dc05-1364.","journal-title":"Diabetes Care"},{"issue":"11","key":"649_CR28","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1210\/en.2007-0370","volume":"148","author":"F Haugen","year":"2007","unstructured":"Haugen F, Drevon CA: Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology. 2007, 148 (11): 5478-5486. 10.1210\/en.2007-0370.","journal-title":"Endocrinology"},{"issue":"2","key":"649_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3132\/dvdr.2008.017","volume":"5","author":"S Plant","year":"2008","unstructured":"Plant S, Shand B, Elder P, Scott R: Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins. Diab Vasc Dis Res. 2008, 5 (2): 102-108. 10.3132\/dvdr.2008.017.","journal-title":"Diab Vasc Dis Res"},{"issue":"6","key":"649_CR30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.urology.2004.12.053","volume":"65","author":"S Goktas","year":"2005","unstructured":"Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S: Prostate cancer and adiponectin. Urology. 2005, 65 (6): 1168-1172. 10.1016\/j.urology.2004.12.053.","journal-title":"Urology"},{"issue":"3","key":"649_CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.33549\/physiolres.930848","volume":"55","author":"D Housa","year":"2006","unstructured":"Housa D, Housova J, Vernerova Z, Haluzik M: Adipocytokines and cancer. Physiol Res. 2006, 55 (3): 233-244.","journal-title":"Physiol Res"},{"issue":"3","key":"649_CR32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1210\/jc.2003-031804","volume":"89","author":"C Mantzoros","year":"2004","unstructured":"Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, et al: Adiponectin and breast cancer risk. J Clin Endocrinol Metab. 2004, 89 (3): 1102-1107. 10.1210\/jc.2003-031804.","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"649_CR33","first-page":"5699","volume":"9","author":"Y Miyoshi","year":"2003","unstructured":"Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 2003, 9 (15): 5699-5704.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"649_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2005.05.047","volume":"237","author":"DC Chen","year":"2006","unstructured":"Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS: Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett. 2006, 237 (1): 109-114. 10.1016\/j.canlet.2005.05.047.","journal-title":"Cancer Lett"},{"issue":"2","key":"649_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/0300985809357753","volume":"47","author":"MP Cleary","year":"2010","unstructured":"Cleary MP, Grossmann ME, Ray A: Effect of obesity on breast cancer development. Vet Pathol. 2010, 47 (2): 202-213. 10.1177\/0300985809357753.","journal-title":"Vet Pathol"},{"key":"649_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2741\/s30","volume":"1","author":"MP Cleary","year":"2009","unstructured":"Cleary MP, Ray A, Rogozina OP, Dogan S, Grossmann ME: Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention. Front Biosci (Schol Ed). 2009, 1: 329-357.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"18","key":"649_CR37","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/00029330-200709020-00009","volume":"120","author":"WK Hou","year":"2007","unstructured":"Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, Sun Y, Wu Q, Chen L: Adipocytokines and breast cancer risk. Chin Med J (Engl). 2007, 120 (18): 1592-1596.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"649_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-2007-956518","volume":"39","author":"JD Arditi","year":"2007","unstructured":"Arditi JD, Venihaki M, Karalis KP, Chrousos GP: Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res. 2007, 39 (1): 9-13. 10.1055\/s-2007-956518.","journal-title":"Horm Metab Res"},{"issue":"4","key":"649_CR39","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.bbrc.2005.12.103","volume":"340","author":"JD Bub","year":"2006","unstructured":"Bub JD, Miyazaki T, Iwamoto Y: Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun. 2006, 340 (4): 1158-1166. 10.1016\/j.bbrc.2005.12.103.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"649_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbrc.2006.04.076","volume":"345","author":"MN Dieudonne","year":"2006","unstructured":"Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R: Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun. 2006, 345 (1): 271-279. 10.1016\/j.bbrc.2006.04.076.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"649_CR41","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mc.20644","volume":"49","author":"JI Fenton","year":"2010","unstructured":"Fenton JI, Birmingham JM: Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3. Mol Carcinog. 2010, 49 (7): 700-709.","journal-title":"Mol Carcinog"},{"issue":"11","key":"649_CR42","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1136\/gut.2008.159293","volume":"57","author":"T Fujisawa","year":"2008","unstructured":"Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, Inamori M, Nakajima N, Watanabe M, Kubota N, et al: Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut. 2008, 57 (11): 1531-1538. 10.1136\/gut.2008.159293.","journal-title":"Gut"},{"issue":"11","key":"649_CR43","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/BF02978210","volume":"28","author":"JH Kang","year":"2005","unstructured":"Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, Roh YK: Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res. 2005, 28 (11): 1263-1269. 10.1007\/BF02978210.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"649_CR44","first-page":"971","volume":"20","author":"E Dos Santos","year":"2008","unstructured":"Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, Pecquery R: Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep. 2008, 20 (4): 971-977.","journal-title":"Oncol Rep"},{"issue":"23","key":"649_CR45","doi-asserted-by":"publisher","first-page":"11462","DOI":"10.1158\/0008-5472.CAN-06-1969","volume":"66","author":"Y Wang","year":"2006","unstructured":"Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A: Adiponectin modulates the glycogen synthase kinase-3beta\/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 2006, 66 (23): 11462-11470. 10.1158\/0008-5472.CAN-06-1969.","journal-title":"Cancer Res"},{"issue":"29","key":"649_CR46","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/onc.2009.129","volume":"28","author":"L Taliaferro-Smith","year":"2009","unstructured":"Taliaferro-Smith L, Nagalingam A, Zhong D, Zhou W, Saxena NK, Sharma D: LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene. 2009, 28 (29): 2621-2633. 10.1038\/onc.2009.129.","journal-title":"Oncogene"},{"key":"649_CR47","doi-asserted-by":"crossref","unstructured":"Saxena NK, Sharma D: Metastasis suppression by adiponectin: LKB1 rises up to the challenge. Cell Adh Migr. 2010, 4 (3):","DOI":"10.4161\/cam.4.3.11541"},{"issue":"1","key":"649_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ygyno.2009.12.018","volume":"117","author":"G Pfeiler","year":"2010","unstructured":"Pfeiler G, Hudelist G, Wulfing P, Mattsson B, Konigsberg R, Kubista E, Singer CF: Impact of AdipoR1 expression on breast cancer development. Gynecol Oncol. 2010, 117 (1): 134-138. 10.1016\/j.ygyno.2009.12.018.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"649_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.maturitas.2009.04.006","volume":"63","author":"G Pfeiler","year":"2009","unstructured":"Pfeiler G, Treeck O, Wenzel G, Goerse R, Hartmann A, Schmitz G, Ortmann O: Influence of insulin resistance on adiponectin receptor expression in breast cancer. Maturitas. 2009, 63 (3): 253-256. 10.1016\/j.maturitas.2009.04.006.","journal-title":"Maturitas"},{"issue":"2","key":"649_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.canlet.2006.10.006","volume":"250","author":"C Takahata","year":"2007","unstructured":"Takahata C, Miyoshi Y, Irahara N, Taguchi T, Tamaki Y, Noguchi S: Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett. 2007, 250 (2): 229-236. 10.1016\/j.canlet.2006.10.006.","journal-title":"Cancer Lett"},{"issue":"3","key":"649_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-007-9874-3","volume":"112","author":"S Nakayama","year":"2008","unstructured":"Nakayama S, Miyoshi Y, Ishihara H, Noguchi S: Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res Treat. 2008, 112 (3): 405-410. 10.1007\/s10549-007-9874-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"649_CR52","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/me.2009-0498","volume":"24","author":"AY Kim","year":"2010","unstructured":"Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, Kim SE, Lee GY, Lee JW, Jung SA, et al: Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol. 2010, 24 (7): 1441-1452. 10.1210\/me.2009-0498.","journal-title":"Mol Endocrinol"},{"issue":"3","key":"649_CR53","first-page":"479","volume":"20","author":"K Yoneda","year":"2008","unstructured":"Yoneda K, Tomimoto A, Endo H, Iida H, Sugiyama M, Takahashi H, Mawatari H, Nozaki Y, Fujita K, Yoneda M, et al: Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep. 2008, 20 (3): 479-483.","journal-title":"Oncol Rep"},{"issue":"1","key":"649_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1677\/ERC-07-0197","volume":"15","author":"CJ Williams","year":"2008","unstructured":"Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP, Tseleni-Balafouta S, Mantzoros CS: Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer. 2008, 15 (1): 289-299. 10.1677\/ERC-07-0197.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"649_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","volume":"1","author":"M Zakikhani","year":"2008","unstructured":"Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN: The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res (Phila). 2008, 1 (5): 369-375. 10.1158\/1940-6207.CAPR-08-0081.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"6","key":"649_CR56","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-09-1805","volume":"16","author":"AM Gonzalez-Angulo","year":"2010","unstructured":"Gonzalez-Angulo AM, Meric-Bernstam F: Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res. 2010, 16 (6): 1695-1700. 10.1158\/1078-0432.CCR-09-1805.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"649_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.01.007","volume":"67","author":"SM Hadad","year":"2008","unstructured":"Hadad SM, Fleming S, Thompson AM: Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol. 2008, 67 (1): 1-7. 10.1016\/j.critrevonc.2008.01.007.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"649_CR58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1158\/1940-6207.CAPR-08-0166","volume":"2","author":"JR Fay","year":"2009","unstructured":"Fay JR, Steele V, Crowell JA: Energy homeostasis and cancer prevention: the AMP-activated protein kinase. Cancer Prev Res (Phila). 2009, 2 (4): 301-309. 10.1158\/1940-6207.CAPR-08-0166.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"13","key":"649_CR59","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-07-6721","volume":"68","author":"W Jiang","year":"2008","unstructured":"Jiang W, Zhu Z, Thompson HJ: Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res. 2008, 68 (13): 5492-5499. 10.1158\/0008-5472.CAN-07-6721.","journal-title":"Cancer Res"},{"issue":"3","key":"649_CR60","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/prot.10104","volume":"47","author":"E Krieger","year":"2002","unstructured":"Krieger E, Koraimann G, Vriend G: Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field. Proteins. 2002, 47 (3): 393-402. 10.1002\/prot.10104.","journal-title":"Proteins"},{"issue":"1","key":"649_CR61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000, 28 (1): 235-242. 10.1093\/nar\/28.1.235.","journal-title":"Nucleic Acids Res"},{"key":"649_CR62","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"DLE Van Der Spoel","year":"2005","unstructured":"Van Der Spoel DLE, Hess B, Groenhof G, Mark AE, Berendsen HJC: GROMACS: fast, flexible, and free. J Comp Chem. 2005, 26: 1701-1718. 10.1002\/jcc.20291.","journal-title":"J Comp Chem"},{"key":"649_CR63","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1021\/jp003919d","volume":"105","author":"GAFR Kaminski","year":"2001","unstructured":"Kaminski GAFR, Tirado-Rives J, Jorgensen WL: Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chamical calculations on peptides. J Phys Chem B. 2001, 105: 6474-6487. 10.1021\/jp003919d.","journal-title":"J Phys Chem B"},{"key":"649_CR64","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/(SICI)1521-3773(19990115)38:1\/2<236::AID-ANIE236>3.0.CO;2-M","volume":"38","author":"XGK Daura","year":"1999","unstructured":"Daura XGK, Jaun B, Steebach D, van Gunsteren WF, Mark AE: Peptide folding: When simulation meets experiment. Angew Chem Int Ed Engl. 1999, 38: 236-240. 10.1002\/(SICI)1521-3773(19990115)38:1\/2<236::AID-ANIE236>3.0.CO;2-M.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"649_CR65","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/bip.360221211","volume":"22","author":"W Kabsch","year":"1983","unstructured":"Kabsch W, Sander C: Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983, 22 (12): 2577-2637. 10.1002\/bip.360221211.","journal-title":"Biopolymers"},{"issue":"1","key":"649_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-1759(02)00137-0","volume":"267","author":"R Frank","year":"2002","unstructured":"Frank R: The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. J Immunol Methods. 2002, 267 (1): 13-26. 10.1016\/S0022-1759(02)00137-0.","journal-title":"J Immunol Methods"},{"issue":"3","key":"649_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1399-3011.1990.tb00939.x","volume":"35","author":"GB Fields","year":"1990","unstructured":"Fields GB, Noble RL: Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res. 1990, 35 (3): 161-214.","journal-title":"Int J Pept Protein Res"},{"issue":"6","key":"649_CR68","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nprot.2007.160","volume":"2","author":"K Hilpert","year":"2007","unstructured":"Hilpert K, Winkler DF, Hancock RE: Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat Protoc. 2007, 2 (6): 1333-1349. 10.1038\/nprot.2007.160.","journal-title":"Nat Protoc"},{"key":"649_CR69","volume-title":"European J Cancer","author":"L Otvos Jr","year":"2011","unstructured":"Otvos L, Kovalszky I, Riolfi M, Ferla R, Olah J, Sztodola A, Namma K, Molino A, Piubello Q, Wade JD, Surmacz E: Efficacy of a Leptin Receptor Antagonist Peptide in a Mouse Model of Triple-negative Breast Cancer. European J Cancer. 2011"},{"issue":"2","key":"649_CR70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1750-3639.2009.00323.x","volume":"20","author":"M Riolfi","year":"2010","unstructured":"Riolfi M, Ferla R, Del Valle L, Pina-Oviedo S, Scolaro L, Micciolo R, Guidi M, Terrasi M, Cetto GL, Surmacz E: Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathol. 2010, 20 (2): 481-489. 10.1111\/j.1750-3639.2009.00323.x.","journal-title":"Brain Pathol"},{"issue":"18","key":"649_CR71","first-page":"6747","volume":"61","author":"M Bartucci","year":"2001","unstructured":"Bartucci M, Morelli C, Mauro L, Ando S, Surmacz E: Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res. 2001, 61 (18): 6747-6754.","journal-title":"Cancer Res"},{"issue":"12","key":"649_CR72","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-08-0642","volume":"68","author":"V Bartella","year":"2008","unstructured":"Bartella V, Cascio S, Fiorio E, Auriemma A, Russo A, Surmacz E: Insulin-dependent leptin expression in breast cancer cells. Cancer Res. 2008, 68 (12): 4919-4927. 10.1158\/0008-5472.CAN-08-0642.","journal-title":"Cancer Res"},{"issue":"19","key":"649_CR73","doi-asserted-by":"publisher","first-page":"6466","DOI":"10.1158\/1078-0432.CCR-04-0203","volume":"10","author":"C Garofalo","year":"2004","unstructured":"Garofalo C, Sisci D, Surmacz E: Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res. 2004, 10 (19): 6466-6475. 10.1158\/1078-0432.CCR-04-0203.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"649_CR74","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jps.2600810802","volume":"81","author":"MF Powell","year":"1992","unstructured":"Powell MF, Grey H, Gaeta F, Sette A, Colon S: Peptide stability in drug development: a comparison of peptide reactivity in different biological media. J Pharm Sci. 1992, 81 (8): 731-735. 10.1002\/jps.2600810802.","journal-title":"J Pharm Sci"},{"issue":"1","key":"649_CR75","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.febslet.2007.11.070","volume":"582","author":"T Kadowaki","year":"2008","unstructured":"Kadowaki T, Yamauchi T, Kubota N: The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett. 2008, 582 (1): 74-80. 10.1016\/j.febslet.2007.11.070.","journal-title":"FEBS Lett"},{"key":"649_CR76","volume-title":"Breast Cancer Res Treat","author":"B Maiti","year":"2009","unstructured":"Maiti B, Kundranda MN, Spiro TP, Daw HA: The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat. 2009"},{"issue":"5","key":"649_CR77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1467-789X.2007.00396.x","volume":"8","author":"L Vona-Davis","year":"2007","unstructured":"Vona-Davis L, Howard-McNatt M, Rose DP: Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev. 2007, 8 (5): 395-408. 10.1111\/j.1467-789X.2007.00396.x.","journal-title":"Obes Rev"},{"issue":"38","key":"649_CR78","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1038\/sj.onc.1207751","volume":"23","author":"EE Calle","year":"2004","unstructured":"Calle EE, Thun MJ: Obesity and cancer. Oncogene. 2004, 23 (38): 6365-6378. 10.1038\/sj.onc.1207751.","journal-title":"Oncogene"},{"issue":"2","key":"649_CR79","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1017\/S0029665108006976","volume":"67","author":"T Pischon","year":"2008","unstructured":"Pischon T, Nothlings U, Boeing H: Obesity and cancer. Proc Nutr Soc. 2008, 67 (2): 128-145. 10.1017\/S0029665108006976.","journal-title":"Proc Nutr Soc"},{"issue":"2","key":"649_CR80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1590\/S0004-27302009000200006","volume":"53","author":"LA Velloso","year":"2009","unstructured":"Velloso LA: The brain is the conductor: diet-induced inflammation overlapping physiological control of body mass and metabolism. Arq Bras Endocrinol Metabol. 2009, 53 (2): 151-158.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"649_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-010-0290-x","volume":"102","author":"G Reynes","year":"2010","unstructured":"Reynes G, Vila V, Martin M, Parada A, Fleitas T, Reganon E, Martinez-Sales V: Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol. 2010, 102 (1): 35-41.","journal-title":"J Neurooncol"},{"issue":"9","key":"649_CR82","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-08-2641","volume":"69","author":"KY Kim","year":"2009","unstructured":"Kim KY, Baek A, Hwang JE, Choi YA, Jeong J, Lee MS, Cho DH, Lim JS, Kim KI, Yang Y: Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation. Cancer Res. 2009, 69 (9): 4018-4026. 10.1158\/0008-5472.CAN-08-2641.","journal-title":"Cancer Res"},{"issue":"11","key":"649_CR83","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/ijc.23436","volume":"122","author":"JI Fenton","year":"2008","unstructured":"Fenton JI, Birmingham JM, Hursting SD, Hord NG: Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min\/+ colon epithelial cells. Int J Cancer. 2008, 122 (11): 2437-2445. 10.1002\/ijc.23436.","journal-title":"Int J Cancer"},{"issue":"4","key":"649_CR84","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1677\/ERC-06-0091","volume":"14","author":"D Barb","year":"2007","unstructured":"Barb D, Neuwirth A, Mantzoros CS, Balk SP: Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway. Endocr Relat Cancer. 2007, 14 (4): 995-1005. 10.1677\/ERC-06-0091.","journal-title":"Endocr Relat Cancer"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6750-11-90.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6750-11-90\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6750-11-90.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T09:28:24Z","timestamp":1713000504000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/1472-6750-11-90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1186\/1472-6750-11-90","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,5]]},"assertion":[{"value":"23 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"90"}}